Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer

Carla V Rothlin1, Jonathan A Leighton, Sourav Ghosh

  • 1*Department of Immunobiology, School of Medicine, Yale University, New Haven, Connecticut; †Division of Gastroenterology, Mayo Clinic, Scottsdale, Arizona; and ‡Department of Cellular and Molecular Medicine and Arizona Cancer Center, University of Arizona, Tucson, Arizona.

Insights

The TAM receptor tyrosine kinases (Tyro3, Axl, Mertk) regulate immune responses and apoptotic cell clearance. Their targeted activation offers a potential therapeutic strategy for inflammatory bowel disease by reducing inflammation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Gastroenterology

Background:

  • The TAM receptor tyrosine kinases (Tyro3, Axl, Mertk) and their ligands (Gas6, Protein S) are key regulators of innate immunity.
  • TAM signaling dampens pro-inflammatory cytokine production and facilitates the clearance of apoptotic cells, preventing excessive inflammation.

Purpose of the Study:

  • To review recent advances in TAM receptor research concerning the resolution of intestinal inflammation.
  • To explore the therapeutic potential of TAM receptor activation in inflammatory bowel disease (IBD).

Main Methods:

  • Review of existing literature on TAM receptor signaling in immune responses.
  • Analysis of studies investigating TAM function in mouse models of inflammation.
  • Examination of the role of TAMs in apoptotic cell clearance and tissue repair.

Main Results:

  • TAM signaling is crucial for resolving inflammation and removing apoptotic cells during immune responses.
  • Dysregulation of TAM pathways may contribute to the pathogenesis of inflammatory bowel disease.
  • Targeted activation of TAM receptors shows promise for managing intestinal inflammation.

Conclusions:

  • The TAM pathway plays a significant role in controlling inflammatory responses within the intestine.
  • Targeted activation of TAM receptor tyrosine kinases presents a potential therapeutic avenue for inflammatory bowel disease.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
31
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
33
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
876
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
37
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K